CVE-2022-45611: Fresenius-Kabi Pharmahelp Firmware

Critical severity, CVSS 9.8. EPSS: 1.2% chance of exploitation in the next 30 days.

An issue was discovered in Fresenius Kabi PharmaHelp 5.1.759.0 allows attackers to gain escalated privileges via via capture of user login information.

Affected products

• Fresenius-Kabi Pharmahelp Firmware: version 5.1.759.0 only

Published 2023-08-22. Last modified 2026-06-17.